VIA
TMO icon

Vident Investment Advisory’s Thermo Fisher Scientific TMO Stock Holding History

Vident Investment Advisory’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,469
Closed -$1.81M – 960
2023
Q2 		$1.81M Sell
3,469
-1,768
-34% -$954K 0.06% 333
2023
Q1 		$3.02M Sell
5,237
-9,687
-65% -$5.46M 0.1% 226
2022
Q4 		$8.22M Buy
14,924
+9,194
+160% +$4.87M 0.31% 73
2022
Q3 		$2.57M Buy
5,730
+359
+7% +$201K 0.08% 268
2022
Q2 		$2.92M Buy
5,371
+2,153
+67% +$1.19M 0.09% 267
2022
Q1 		$1.9M Sell
3,218
-1,500
-32% -$862K 0.05% 477
2021
Q4 		$3.15M Sell
4,718
-69
-1% -$43.1K 0.08% 280
2021
Q3 		$2.73M Sell
4,787
-8,040
-63% -$4.41M 0.08% 266
2021
Q2 		$6.47M Buy
12,827
+1,400
+12% +$661K 0.2% 90
2021
Q1 		$5.22M Buy
11,427
+7,974
+231% +$3.81M 0.18% 101
2020
Q4 		$1.61M Sell
3,453
-21
-0.6% -$9.85K 0.07% 372
2020
Q3 		$1.53M Buy
3,474
+307
+10% +$127K 0.08% 350
2020
Q2 		$1.15M Buy
3,167
+2,221
+235% +$744K 0.06% 433
2020
Q1 		$268K Buy
+946
New +$298K 0.02% 704
2018
Q2 		– Sell
-1,916
Closed -$415K – 970
2018
Q1 		$415K Sell
1,916
-469
-20% -$98.4K 0.02% 691
2017
Q4 		$452K Buy
+2,385
New +$457K 0.02% 603
2015
Q4 		– Sell
-30
Closed -$4K – 802
2015
Q3 		$4K Buy
30
+5
+20% +$651 ﹤0.01% 922
2015
Q2 		$3K Buy
+25
New +$3.26K ﹤0.01% 1047

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vident Investment Advisory's TMO Position: Q3 2023 in Review

Vident Investment Advisory sold out of Thermo Fisher Scientific (TMO) in Q3 2023, closing a stake of 3,469 shares — an estimated $1.81M sold.

Vident Investment Advisory first reported a position in TMO in Q2 2015 and held it in 18 quarters. The position peaked at $8.22M in Q4 2022. 2,364 funds tracked by Wall St. Rank hold TMO as of Q3 2023.

  • Vident Investment Advisory reported no remaining Thermo Fisher Scientific position as of Q3 2023 after selling out during the quarter.
  • Vident Investment Advisory sold 3,469 Thermo Fisher Scientific shares in Q3 2023, an estimated $1.81M.
  • Vident Investment Advisory first reported a position in Thermo Fisher Scientific in Q2 2015 and held it in 18 quarters.
  • Vident Investment Advisory's Thermo Fisher Scientific position peaked at $8.22M in Q4 2022.
  • 2,364 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2023.

Based on Vident Investment Advisory's 13F filing for Q3 2023.